PRJNA501862
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine
ETNK1-mutated cell lines as well as primary leukemic cells show a significant increase in mitochondrial activity, ROS production, Histone H2AX phosphorylation and a higher mutation rate compared to WT